ProCE Banner Activity

Safety Considerations for HIV Treatments During Pregnancy

Podcast Episodes

Listen to expert insights from Dr. Jean Rene Anderson and Dr. William Short on their approach to optimizing HIV treatments during pregnancy.

Released: August 23, 2022

Expiration: August 22, 2023

Share

Faculty

Jean Rene Anderson

Jean Rene Anderson, MD

Professor
Department of Gynecology and Obstetrics
Johns Hopkins University
Director, Johns Hopkins HIV Women’s Health Program
Johns Hopkins Medical Institutions
Baltimore, Maryland

William R. Short

William R. Short, MD, MPH, FIDSA

Associate Director of the HIV Clinical Trials Unit
Associate Professor of Medicine
Division of Infectious Diseases
Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by educational grants from

Janssen Therapeutics, Division of Janssen Products, LP

ViiV Healthcare

Faculty Disclosure

Primary Author

Jean Rene Anderson, MD

Professor
Department of Gynecology and Obstetrics
Johns Hopkins University
Director, Johns Hopkins HIV Women’s Health Program
Johns Hopkins Medical Institutions
Baltimore, Maryland

Jean Rene Anderson, MD: researcher: Gilead Sciences; individual publicly traded stocks and stock options: AbbVie, Merck.

William R. Short, MD, MPH, FIDSA

Associate Director of the HIV Clinical Trials Unit
Associate Professor of Medicine
Division of Infectious Diseases
Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania

William R. Short, MD, MPH, AAHIVS: consultant/advisor/speaker: Janssen, ViiV.